Virtual Group-Based Physical Activity for Cancer Survivors

Overseen By Celina H Shiraizipour, Ph.D.

Age: 18 - 65

Sex: Any

Trial Phase: Academic

Sponsor: Cedars-Sinai Medical Center

Must not be taking: AR-targeted therapies

Disqualifiers: Pregnancy, Metastatic disease, Neuropathy, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

Duration: 12 weeks

8 Participants Needed

Trial Summary

What is the purpose of this trial?

The purpose of this prospective, interventional, single-arm pilot study is to evaluate whether virtually delivered group-based physical activity is feasible for adolescent and young adult (AYA) cancer survivors. AYAs who were diagnosed with cancer and have completed cancer treatment will be recruited for this study. This study will enroll 20 participants in total and will last approximately 3 months.

Research Team

Susan Whiteway, LtCol USAF, MD

Principal Investigator

Walter Reed National Military Medical Center

Celina H Shirazipour, Ph.D.

Principal Investigator

Cedars-Sinai Medical Center

Eligibility Criteria

This trial is for young adult cancer survivors aged 18-39 who have finished treatment at least 3 months ago, are not currently very active, and can use internet-connected devices. It's not for those with severe hearing or vision loss, pregnant individuals, or anyone planning to undergo major cancer treatments within the next three months.

Inclusion Criteria

You are not currently exercising enough based on a questionnaire about leisure-time physical activity.

You were diagnosed with any type of cancer when you were between 15 and 39 years old.

Written informed consent obtained from subject and ability for subject to comply with the requirements of the study

Exclusion Criteria

You have difficulty hearing or seeing, which would make it hard for you to use the app. Using hearing aids or visual aids is allowed.

Currently pregnant, based on self-report

Patients with active treatment planned within the next 3 months. (Active treatment includes chemotherapy, biologic therapy, radiation therapy, surgery, and any combination.) Long-term hormonal/biologic treatments are acceptable except for AR-targeted therapies for prostate cancer. Participants with known metastatic disease, grade 3 or higher neuropathy, major surgery within 3 months of baseline visit, pregnancy of childbearing potential will be excluded.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants engage in a 12-week virtual physical activity program via BurnAlong, including group discussions and live sessions with an exercise physiologist

12 weeks

Weekly virtual sessions, monthly live sessions

Follow-up

Participants are monitored for safety and effectiveness after treatment, including surveys and physical assessments

4 weeks

Treatment Details

Interventions

• Social Media Discussion Board
• Virtual group based physical activity (BurnAlong)

Trial Overview The study tests a virtual group exercise program called BurnAlong and a social media discussion board to see if they're doable for these survivors. All participants will try out the online fitness classes and join discussions over about three months.

Participant Groups

Group I: Virtual Group-Based Physical Activity (BurnAlong) and Discussion Board Experimental Treatment 1 Intervention

Participants will be asked to complete a 12 week virtual physical activity program delivered by the BurnAlong app, participate in a discussion board, and engage in live physical activity sessions with an exercise physiologist.

Who Is Running the Clinical Trial?

Cedars-Sinai Medical Center

Lead Sponsor

Trials

523

Recruited

165,000+

Walter Reed National Military Medical Center

Collaborator

Trials

149

Recruited

33,800+